NEW YORK, Dec. 16, 2023 /PRNewswire/ — Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced the appointment of Zhijun (Michael) Liang, as an independent director of the Company, effective January 1, 2024.

Zhijun (Michael) Liang, has spent more than two decades providing management consulting and investment management services, primarily to start-ups and growth businesses, enabling them to address expansion needs and financial challenges. He co-founded Beijing Yuantong Funds Management Co., Ltd., and has led its risk and investment management since 2018. Concurrently, as the Managing Partner of Shanghai Tongdai Business Management Consulting LLP, he manages the firm’s financial and management advisory services, dedicated to delivering premium solutions tailored to the unique needs of its clients.

Mr. Liang holds an MBA degree in general management from HEC Montreal, the business school of the University of Montreal and a Bachelor of Arts degree in English Language and Literature from South-Central University for Nationalities (PRC).

The Board has determined that Mr. Liang is independent within the meaning of Nasdaq Listing Rule 5605(a)(2).

There are no family relationships between Mr. Liang and any other officer or member of the Board of Directors of the Company.

About Fresh2 Group Limited

Fresh2 Group Limited is engaged in the business-to-business e-commerce and supply chain sectors. Committed to helping restaurants lower procurement costs and improve efficiency, Fresh2 utilizes an advanced supply chain management system. By applying strategic digital technologies and innovative business models, Fresh2 is driving the online transformation of the restaurant supply industry. Fresh2 aims to refine restaurant operations, adding significant value to the food industry, and building a global network of restaurateurs in the digital age For more information, visit: https://fresh2.co/investors. 

Source : Appointment of New Independent Director

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Acquisition will extend the company’s leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment

JENA, Germany, Dec. 16, 2023 /PRNewswire/ — Carl Zeiss Meditec AG announced today that it has entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) B.V. (D.O.R.C.) from the investment firm Eurazeo SE, Paris, France. The acquisition will enhance and complement ZEISS Medical Technology’s broad ophthalmic portfolio and range of digitally connected workflow solutions for addressing a wide variety of eye conditions, including retinal disorders, cataracts, glaucoma and refractive errors.

Dutch Ophthalmic Research Center (D.O.R.C.)

D.O.R.C., a leading player in the retinal surgical devices market, will be a key contributor to ZEISS Medical Technology’s long-term strategy and success going forward. With the acquisition, ZEISS will expand its position in the vitreo-retinal (VR) surgery segment, further strengthening its position as the fastest growing manufacturer of ophthalmic medical devices globally. D.O.R.C.’s products are used by ophthalmic surgeons around the world to treat a wide range of vision-threatening conditions. Their innovative portfolio of devices, disposables and liquids for ophthalmic surgeries are a strong complement to the ZEISS Medical Technology portfolio.

D.O.R.C. also brings to the acquisition one of the market’s most advanced dual-function systems – the EVA NEXUS™ platform. EVA NEXUS™ is the core of a strong portfolio, comprising of a dual-capable system and a full range of accessories, instruments and liquids offering a best-in-class solution across VR, cataract, and combined procedures, ensuring surgeons can rely on a single platform to cater to a variety of procedure types. 

"With the acquisition of Dutch Ophthalmic Research Center, we’ll bring together two highly innovative ophthalmic powerhouses to accelerate ZEISS’s position in the vitreo-retinal surgery segment and extend our leadership in the ophthalmic medical devices market," says Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG.

"Meeting our customers’ growing surgical needs to improve patients’ lives is the cornerstone of this acquisition," says Euan S. Thomson, Ph.D., Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. "By joining forces with Dutch Ophthalmic Research Center, we will greatly enhance our ZEISS Retina Workflow and overall portfolios for both posterior and anterior surgery segments, helping to firmly establish our position as a leading solutions provider in the global retinal surgery market."

"In the year when D.O.R.C. celebrates 40 years of innovation in ophthalmic surgery, we could not be more excited to join a market leader and visionary like ZEISS Medical Technology," says Pierre Billardon, CEO of Dutch Ophthalmic Research Center, International. "We’ve built an amazing business with innovative, market-leading products and look forward to seizing this opportunity for growth and advancing the future of ophthalmic surgery. I am personally proud and immensely grateful to all of the team at D.O.R.C. for their commitment and expertise to help patients see again."

The acquisition is valued at approximately EUR 985 million and is expected to close in the first half of calendar year 2024. The transaction remains subject to applicable regulatory and antitrust approvals. RBC Capital Markets served as exclusive financial advisor to the transaction.

Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development.

Contact for investors:
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: [email protected]

Contact for the press: 

Jörg Nitschke
Head of Corporate Brand, Communications and Public Affairs
ZEISS Group
+49 7364 20-3242
Mail: [email protected]

Frank E. Smith  
Head of Global Communications, ZEISS Ophthalmology
Carl Zeiss Meditec 
Phone: +1 925 487 3036 
Mail: [email protected] 

www.zeiss.com/newsroom

Company profiles:

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With approximately 4,823 employees worldwide, the Group generated revenue of €2,089.3m in fiscal year 2022/23 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG’s shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For further information visit: www.zeiss.com/med

About D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.

D.O.R.C. is one of the world’s leading suppliers of equipment, instruments and liquids for ophthalmic surgery. For 40 years, D.O.R.C. has grown into a successful international business, shaping its product portfolio through close collaboration with leading top surgeons. The company improves eye surgery globally and maximizes surgeon control by providing innovative quality approaches for eye disorders. Its products are exported to more than 80 countries worldwide. The company is headquartered in Zuidland, the Netherlands, and has more than 750 employees.

Source : Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

XUZHOU, China, Dec. 16, 2023 /PRNewswire/ — The XGT15000-600S, the world’s largest tower crane with the biggest double-boom parallel combination that is jointly developed by XCMG Machinery (SHE: 000425, "XCMG") and China Railway Major Bridge Engineering Co., Ltd. ("MBEC"), has recently been recognized by 11 leading industry experts in technical appraisal for its advanced technological achievements and production performance.

The development team of XCMG and MBEC solved the bottlenecks of super-large lifting capacity and lifting height. The XGT15000-600S tower crane has achieved four major technological breakthroughs and is advantaged in terms of high safety level, intelligent technology, strong functionality, high quality, precise modules, and excellent performance.

"The XGT15000-600S has a rated lifting moment of 15,000t•m, a maximum lifting capacity of 600t, an overall weight of over 4,000 tons, a maximum independent height of 92.5 meters and a maximum attachment height of 400 meters," said Mi Chenghong of XCMG.

Four major breakthroughs powering up the world’s largest tower crane

XCMG has successfully created the XGT15000-600S super tower crane with a decade of continuous exploration and development as the foundation.

The parallel combination boom system design technology for tower cranes with large lifting capacity and lifting height has created a new spatial dispersion distribution of hoisting wire ropes and proposed a new configuration of double-boom parallel combined tower crane with four trolleys and four lifting hooks. It solved the problem of super-large lifting weight of 600 tons and the height of 400 meters, greatly improving the production, transportation, and installation of super-large boom structure. The multi-mechanism, high-security coordinated operation and precision control technology for the super-scale tower crane pioneers a cooperative operation technology for the four-mechanism, double-amplitude tower crane. It tackles the problem of reliable synchronization of multi-mechanism, multi-cylinder large-tonnage tower cranes as well as cylinder failure to boost control precision, reliability, and safety. The high-efficiency application of multi-functional combination and design technology for automatic trimming and continuous jacking structure brings a new multi-combination and efficient application use mode of the tower crane, greatly improving the product use efficiency. The automatic trimming and continuous jacking technology also elevates the jacking efficiency. The status monitoring and intelligent maneuver technology for super-scale tower crane leverages digital twin technology to monitor the whole process of the tower crane’s structural stress, deformation, vibration, and handling data in real-time, achieving digitalized, visualized, and intelligent operation of the auxiliary lifting control.

The XGT15000-600S was developed over the course of 14 months. Officially launched and delivered on June 2, 2022, the tower crane breaks through more than 60 core technologies, set 10 world records, and achieved 10 industry firsts. In total, the project applied for 72 patents, 47 patents have been authorized. It applied for 35 patents for invention, with 10 already being authorized, alongside three software copyrights.

The mega tower crane has served in the constructions of major bridges, including the Changtai Yangtze River Bridge, which is the world’s largest highway and railway cable-stayed bridge with main tower of 352 meters, maximum hoisting module weight of 330 tons and hoisting height of 370 meters, as well as the largest three-tower cable-stayed bridge – Chao-Ma Railway Bridge of the Ma’anshan Yangtze River Bridge with main tower of 345 meters, maximum hoisting module weight of 505 tons and height reaching 365 meters.

The XGT15000-600S has completed an accumulative 5,000 hours of operation, presenting robust lifting capacity, smooth operation, precise control, high-efficiency assembly, and disassembly with intelligent operation enabled.

Source : World's First and Largest Tower Crane Receives Recognition from 11 Industry Experts in Technical Appraisal

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

LOS ANGELES, Dec. 16, 2023 /PRNewswire/ — Netmarble, a leading developer and publisher of high-quality video games, announces the start of the second Closed Beta Test (CBT) for PARAGON: THE OVERPRIME on PlayStation 5. The CBT starts today through January 8 in the United States, Europe, and Russia. Interested players can register for the beta on the  PARAGON: THE OVERPRIME website for access.

This new CBT adds three new heroes from the PC version featuring Morigesh, Yin, and MARTY:. Additionally, based on player feedback, several changes have been made for the upcoming CBT, including an alternate  D-pad layout to provide a more flexible control method, an auto-purchase feature for in-game items, as well as various improvements to the UI and camera movements used by the controller.

Joining this Closed Beta Test will reward players with Grux’s Special winter skin "Red Nosed," which will carry over to the live game, special emotes, as well as 100 Kima. During the second week of the CBT, five of the winter 2022 skins will be rewarded to participants. Additional rewards are planned to celebrate the new year as well.

To celebrate the game’s one-year Early Access, every player, including those on PC, will receive Grux’s Special winter skin "Red Nosed." To celebrate the year-end season, the Agnis of Light will be decked out with a winter theme, with five holiday skins added as well.

PARAGON: THE OVERPRIME is a team-based TPS Action MOBA that anyone can play for free on PC and will be available via PlayStation 5! Players are engaged in 5v5 play while working with teammates to conquer the Prime battlefield. The game celebrates strategic actions and fast-paced battles by two teams aiming to eliminate the opponents’ territories. Players can choose from one of the many powerful heroes utilizing their unique skills – Warrior, Support, Ranger, Caster, Tank, and Assassin.

To stay up to date with all PARAGON: THE OVERPRIME  news and updates, follow the official brand website, Discord, PlayStation 5 wishlist and Twitter. 

About Netmarble Corporation

Established in Korea in 2000, Netmarble Corporation is a leading developer and publisher of top-grossing mobile games worldwide.  Through powerful franchises and collaborations with acclaimed IP holders, Netmarble strives to elevate the gaming experience and entertain audiences globally. As a parent company of Kabam and SpinX Games, and a major shareholder of Jam City and HYBE (formerly Big Hit Entertainment). More information can be found at http://company.netmarble.com.

Source : RING IN THE HOLIDAYS WITH PARAGON: THE OVERPRIME'S SECOND PLAYSTATION 5 CLOSED BETA TEST

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

NEW YORK, Dec. 16, 2023 /PRNewswire/ — Ubie, Inc., headquartered at 1460 Broadway, New York, NY 10036 and led by CEO Kota Kubo, proudly announces that the Japanese version of Ubie’s AI Symptom Checker (https://ubie.app/) has been awarded the "Best with AI" at the Google Play Best of 2023. This prestigious recognition precedes Ubie’s forthcoming launch of the Android app version in the U.S. market.

Since its launch in Japan in 2020, Ubie’s AI Symptom Checker has amassed over 100 million total uses, serving as a testament to its substantial impact bringing patients and medical care closer together. Following its success in Japan, the U.S. version, released in 2022, has already surpassed 2 million uses (press release), further facilitating the connection between healthcare providers and those in need of medical guidance. Kota Kubo, CEO of Ubie, Inc., states, "We are poised to continue this trajectory of growth and are excited to announce plans for the upcoming release of our Android app in the U.S. market." Ubie, Inc. remains steadfast in its commitment to expanding and enhancing its services, striving to exceed customer expectations and contributing to the betterment of global healthcare accessibility.

About Google Play Best of 2023

The Google Play Best of 2023, endorsed by Google Play, is an esteemed event that showcases the most celebrated applications and content across various categories within the Google Play Store. This program culminates in the recognition of exceptional digital offerings, with the category winners determined by a panel of judges within Google Play and is designed to recognize the contribution of developers on the Play Store in relation to a specific category.

Proudly, Ubie has been distinguished as the "Best with AI" category winner. This prestigious award is a reflection of Ubie’s dedication to integrating artificial intelligence in ways that truly enhance user experiences and address real-world needs.

For an in-depth look at the Google Play Best of 2023 and to view the esteemed roster of honorees, please visit the official site: http://play.google.com/best-of-2023

*Google Play is a registered trademark of Google LLC.

About Ubie’s AI Symptom Checker:

US Version: https://ubiehealth.com
Japanese Version: https://ubie.app

Ubie’s AI Symptom Checker enables users to easily access healthcare information and find appropriate healthcare providers. Available in both Japanese and English, it supports users in identifying symptoms and connecting with the right healthcare providers.

About Ubie, Inc.:

Ubie, Inc., established in 2017, is at the forefront of the digital health revolution. As an innovative startup, Ubie harnesses the power of artificial intelligence to seamlessly navigate individuals towards appropriate healthcare services. Our mission is rooted in the belief that everyone, regardless of location or circumstance, deserves access to comprehensive healthcare. We are committed to transforming this vision into reality by creating a more accessible and user-friendly healthcare experience.

Our global presence is anchored at our headquarters in Tokyo, Japan, situated at the heart of Nihonbashi-Horidomecho, and our U.S. headquarters in the bustling hub of New York City. These strategic locations enable us to cultivate and expand our impact on the healthcare industry worldwide.

U.S. Headquarters:
1460 Broadway, New York, NY 10036

Japan Headquarters:
6th Floor, Nihonbashi-Horidomecho 2-chome Bldg.
2-4-3, Horidomecho, Nihonbashi, Chuo-ku, Tokyo, 103-0012

Inception:
May 2017 – Japan Operations
October 2022 – U.S. Operations

Leadership:

Co-founders, Kota Kubo and Dr. Yoshinori Abe, spearhead our ambitious journey with a shared dedication to enhancing healthcare accessibility through innovative solutions.

Discover more about our vision and endeavors at: https://ubiehealth.com/company

Disclaimer: Please be advised that Ubie’s AI Symptom Checker is intended solely for informational purposes and does not constitute a substitute for professional medical diagnosis, advice, or a treatment plan. Users should always seek the advice of qualified health professionals regarding any medical conditions or treatment decisions.

Contact:
Ryosei Hatakeyama
Ubie, Inc.
1460 Broadway, New York, NY 10036
Email: [email protected]

Source : Ubie Won the "Best with AI" in Google Play Best of 2023 (Japan)

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SEATTLE, Dec. 16, 2023 /PRNewswire/ — Quark Expeditions, the global leader in polar adventures, extended its longstanding record of achievement in Antarctica by successfully landing 208 explorers on two voyages for an experience that few on the planet will ever have: walking on sea ice to visit the remote Snow Hill Island colony of Emperor penguins.

Photo Credit: David Merron

Quark Expeditions’ technologically-advanced expedition ship, Ultramarine, and its team delivered these successful Snow Hill voyages in November and December, while also hosting a special onboard ceremony at the edge of Antarctica’s Weddell Sea: the official announcement of Dr Sian Proctor as Ultramarine’s godmother.

Joined by the company’s legendary Expedition Leader, Shane Evoy, together with ship’s Captain Jurak Zekan and the full Expedition Team plus Emperor-inspired Snow Hill guests, Dr Proctor embraced the maritime tradition that celebrates strong women as touchstones for a ship’s good fortune and safe passage at sea. With her unique experience as an artist, astronaut, educator, geoscientist, and advocate for inclusivity, Dr Proctor also looked boldly ahead as a trailblazer and storyteller to guide the ship and its polar ambassadors for years to come.

"My goal as an astronaut and an artist is to inspire," said Dr Proctor. "I am so honored to be godmother for Ultramarine—a role that will allow me to lead by example and to share the personal stories that will inspire others to go out into the world, to experience something new and to become, in their own amazing way, part of the next generation of explorers."

"It’s one thing to be the first to achieve the extraordinary, as we did nearly 20 years ago when we landed at Snow Hill," said Andrew White, President of Quark Expeditions. "But beyond simply being first, our passion drives us to do the extraordinary again and again—staying at the forefront of capability and technology, and building an ever-deepening wealth of experience. We may not be able to voyage off the planet, as Dr Proctor has done, but we will always go together with our polar explorers to find life-changing experiences at its farthest edges."

For the recent sailings of Emperor Penguin Quest: Expedition to Snow Hill, Quark Expeditions guests onboard Ultramarine approached to within 20 nautical miles of Snow Hill Island at the northern edge of Antarctica’s Weddell Sea. Small groups flew in Ultramarine’s Airbus H-145 helicopters to a staging site at a significant distance from the Emperor penguin colony. Every guest walked several kilometres over sea ice to reach the colony (incredible photos here on Instagram) and observed IAATO wildlife protocol throughout the visit. Guests and experts alike, including researchers from the British Antarctica Survey and the Smithsonian Institute that joined the expedition, were thrilled to find the Emperor penguin colony’s adults and younger birds thriving and in good health.

While this season’s Snow Hill sailings to visit the Emperors are now complete, Quark Expeditions advises that a profusion of penguins still awaits in Antarctica, with limited last-minute availability for voyages in coming weeks—click to learn more about the company’s upcoming Penguin Safari and Epic Antarctica expeditions!

For media Inquiries: email [email protected]

About Quark Expeditions: The global leader in polar adventures for more than 30 years. The most passionate and seasoned team in the industry, taking explorers to the ends of the earth. Going where few ever dream, and walking where few ever will. Delivering extraordinary experiences and enriching lives through travel, Quark Expeditions is a Travelopia specialist company.

Photo – https://mma.prnasia.com/media2/2302209/Quark_Expeditions.jpg?p=medium600

Logo – https://mma.prnasia.com/media2/465074/Quark_Expeditions_Logo.jpg?p=medium600

Source : Snow Hill Success!–Quark Expeditions Goes Beyond in Antarctica

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Revolutionary AI-based tool makes complex simulations more than 10,000X faster.

HOUSTON, Dec. 16, 2023 /PRNewswire/ — Xccelerate AI is thrilled to announce a groundbreaking AI-based framework that is set to revolutionize the world of engineering simulations. This innovative leap promises to swiftly predict simulation results, dramatically speeding up complex engineering simulations unleashing a whirlwind of benefits for industries far and wide.

Complex simulations in engineering traditionally demands extensive computational power and time, sometimes taking days to weeks to complete, wreaking havoc on project schedules and budgets.

‘At Xccelerate AI, we are deeply committed to pushing the boundaries of what’s possible in engineering and product development,’ states Dr. Burak Ozturk, CEO of Xccelerate AI. ‘Our innovative AI-based framework is a testament to this commitment, providing a transformative solution that not only accelerates simulation times but also empowers designers and engineers to innovate more freely, explore new possibilities, and achieve excellence in product development. We are ushering in a new era of speed, precision, and efficiency, and we’re excited to see the incredible impact this will have across various industries.’

What’s more, this innovative approach isn’t confined to a single industry. It’s an industry-agnostic solution, catering to anyone who relies on digital simulations for product design and manufacturing. Originally crafted to expedite structural analyses in the automotive sector, its applications have now expanded across various industries.

The framework operates on a straightforward concept: it learns from existing simulation data to predict results for new designs. Many organizations already possess the requisite simulation data for model training, enabling implementation of a bespoke surrogate model for their products in just a few short days. For those without pre-existing data, Xccelerate AI offers extensive expertise in modeling complex phenomena and can assist in cost-effectively acquiring the necessary data.

‘This framework represents a monumental leap forward in simulation technology,’ says Dr. Kaan Inal, the lead visionary behind Xccelerate AI’s cutting-edge framework. ‘By leveraging advanced machine learning, we’ve turned what used to be weeks of computation into mere seconds, without sacrificing accuracy. This is more than just a step change; it’s a whole new paradigm that opens limitless possibilities for innovation across industries.’

About Xccelerate AI:

Leveraging a decade of unparalleled research, Xccelerate AI has developed simulation tools that integrate the predictive capabilities of machine learning to substantially expedite product development. Collaborating with major automotive OEMs and other leading entities in Silicon Valley, as well as across North America and Europe, our technology has transitioned from research laboratories to industry, where it solves complex real-world industrial challenges.

At Xccelerate AI, our team of industry experts, simulation consultants, and data scientists, can help you blend simulation and AI expertise to accelerate your design process. Whether you require a surrogate model for a particular application or a comprehensive solution to a specific challenge, our team is ready to assist. Book a free consultation to discover how our service-based model, client-focused collaboration, and profound AI and simulation knowledge can provide tailor-made solutions, ensuring precision-engineered performance and unparalleled results for your unique needs.

Source : Xccelerate AI Unveils Groundbreaking Achievement for Lightning Fast Engineering Simulations

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network